Tumor necrosis factor inhibits glucocorticoid receptor function in mice: a strong signal toward lethal shock

Tom Van Bogaert1, Sofie Vandevyver, Lien Dejager

  • 1Department for Molecular Biomedical Research, VIB, 9052 Ghent, Belgium.

Insights

Tumor necrosis factor-alpha (TNFα) causes glucocorticoid resistance (GCR) by reducing glucocorticoid receptor (GR) levels. This compromises dexamethasone

Area of Science:

  • Immunology
  • Molecular Biology
  • Pharmacology

Background:

  • Glucocorticoid resistance (GCR) is a significant clinical challenge.
  • Tumor necrosis factor-alpha (TNFα) is a key pro-inflammatory mediator in various diseases.

Purpose of the Study:

  • To investigate if TNFα compromises glucocorticoid receptor (GR) function.
  • To elucidate the molecular mechanisms underlying TNFα-induced GCR.

Main Methods:

  • Mice were treated with dexamethasone and TNFα to assess protection against lethality.
  • GR-dependent gene expression in the liver was analyzed.
  • GR mRNA and protein levels were quantified in the presence and absence of adrenal glands.

Main Results:

  • Dexamethasone failed to protect against TNFα-induced lethality when administered after TNFα stimulation, indicating compromised GR function.
  • TNFα significantly reduced GR mRNA and protein levels, independent of glucocorticoid production.
  • GR heterozygous mice exhibited exacerbated responses to TNFα, supporting the role of GR levels.

Conclusions:

  • TNFα induces GCR by down-regulating GR expression, thereby amplifying inflammatory responses.
  • Understanding TNFα-mediated GCR is crucial for managing inflammatory diseases involving TNFα.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...